Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-42630 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- VMA21 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- Peptide sequence: MERPDKAALN ALQPPEFRNE SSLASTLKTL LFFTALMITV PIGLYFTTKS
- Concentration
- 1 mg/mL
Submitted references Vacuolar Membrane ATPase Activity 21 Predicts a Favorable Outcome and Acts as a Suppressor in Colorectal Cancer.
Zhang F, Shen H, Fu Y, Yu G, Cao F, Chang W, Xie Z
Frontiers in oncology 2020;10:605801
Frontiers in oncology 2020;10:605801
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of human HepG2 cell lysate using an anti-VMA21 polyclonal antibody (Product # PA5-42630).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemistry analysis of human kidney tissue using an anti-VMA21 polyclonal antibody (Product # PA5-42630).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 1 VMA21 is elevated in colorectal cancer. (A) Expression patterns of five assembly factor genes of the V 0 domain of V-ATPase based on TCGA-CRC mRNA data. (B) Immunostaining of VMA21 in CRC and noncancerous tissues. (C) VMA21 protein expression in normal, adenoma, and CRC tissue specimens. (D) Expression pattern of the VMA21 protein in colon cancer and rectal cancer. CORD, colon cancer; READ, rectum cancer.
